EFFECT OF EXOGENOUS TESTOSTERONE ON PROSTATE VOLUME, SERUM AND SEMEN PROSTATE SPECIFIC ANTIGEN LEVELS IN HEALTHY YOUNG MEN
- 1 February 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 159 (2) , 441-443
- https://doi.org/10.1016/s0022-5347(01)63944-2
Abstract
Purpose: We investigate and define the effects of exogenous testosterone on the normal prostate. Materials and Methods: A total of 31 healthy volunteers 21 to 39 years old were randomized to receive either 100, 250 or 500 mg. testosterone via intramuscular injection once a week for 15 weeks. Baseline measurements of serum testosterone, free testosterone and prostate specific antigen (PSA) were taken at week 1. Semen samples were also collected for PSA content and prostate volumes were determined by transrectal ultrasound before testosterone injection. Blood was then drawn every other week before each testosterone injection for the 15 weeks, every other week thereafter until week 28 and again at week 40. After the first 15 weeks semen samples were again collected, and prostate volumes were determined by repeat transrectal ultrasound. Results: Free and total serum testosterone levels increased significantly in the 250 and 500 mg. dose groups. No significant change occurred in the prostate volume or serum PSA levels at any dose of exogenous testosterone. Total semen PSA levels decreased following administration of testosterone but did not reach statistical significance. Conclusions: Despite significant elevations in serum total and free testosterone, healthy young men do not demonstrate increased serum or semen PSA levels, or increased prostate volume in response to exogenous testosterone injections.Keywords
This publication has 21 references indexed in Scilit:
- The effect of exogenous testosterone on total and free prostate specific antigen levels in healthy young menJournal of Urology, 1996
- Prostate Specific Antigen in the Expressed Prostatic Fluid of Men with Benign Prostatic Hyperplasia and Prostate CarcinomaJournal of Urology, 1995
- Prostate volume in testosterone‐treated and untreated hypogonadal men in comparison to age‐matched normal controlsClinical Endocrinology, 1994
- Androgen induction of a human prostate-specific kallikrein, hKLK2: Characterization of an androgen response element in the 5' promoter region of the geneBiochemistry, 1993
- Kinetic evidence for a unique testosterone-receptor complex in 5α-reductase sufficient genital skin fibroblasts and the effects of 5α-reductase deficiency on its formationThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Basis for hormonal management of advanced prostate cancerCancer, 1993
- Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen esterJournal of Clinical Endocrinology & Metabolism, 1992
- Effects of testosterone supplementation in the aging maleJournal of Clinical Endocrinology & Metabolism, 1992
- Characterization of the Prostate-specific Antigen gene: A novel human kallikrein-like geneBiochemical and Biophysical Research Communications, 1989
- 3 Changing concepts of active androgens in bloodClinics in Endocrinology and Metabolism, 1986